Literature DB >> 15902709

Dominating prevalence of P[8],G1 and P[8],G9 rotavirus strains among children admitted to hospital between 2000 and 2003 in Budapest, Hungary.

Krisztián Bányai1, Jon R Gentsch, Renáta Schipp, Ferenc Jakab, Edina Meleg, Ilona Mihály, György Szücs.   

Abstract

Group A rotaviruses are the main cause of acute dehydrating diarrhea in children, responsible for high mortality in developing countries and a significant socio-economic burden associated with treating the disease in developed countries. Two rotavirus vaccine candidates predicated on either homotypic or heterotypic protection have undergone clinical trials recently and await licensure for routine use. In anticipation of a future vaccination campaign in Hungary, the diversity of rotaviruses collected from Budapest between 2000 and 2003 were analyzed by polyacrylamide gel electrophoresis (PAGE) of the viral genome and by serotyping and genotyping of the outer capsid genes, VP7 and VP4. Among 2,763 rotavirus positive specimens available for analysis, we were able to determine the electropherotype of 2,227, and, of these, 1,517 (68.1%) were subjected to G typing and 1,173 (52.7%) were subjected to P typing. We successfully G typed 1,481 (97.6%) and P typed 1,130 (96.3%) strains, respectively. A total of six G types (G1, 50.2%; G2, 2.2%; G3, 1.7%; G4, 5.8%; G6, 0.6%; and G9, 34.4%) and four P types (P[4], 3.0%; P[6], 0.7%; P[8], 89.9%; and P[9], 1.7%) were identified in nine individual combinations (P[8],G1; P[4],G2; P[8],G3; P[8],G4; P[8],G9; P[6],G4; P[4],G1; P[9],G3; and P[9],G6). The prevalence of VP7 and VP4 specificities varied from year to year. In this regard, a shift in serotype predominance from G1 in 2000-2001 (61.8%) and 2001-2002 (69.7%) to G9 in 2002-2003 (51.3%) was an intriguing observation that has been reported recently in some other countries, as well. The emergence of serotype G9 rotaviruses in Hungary and other parts of the world may have implications for future vaccine development and use, particularly, if current vaccine candidates cannot confer adequate homotypic or heterotypic protection against these strains. Copyright (c) 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15902709     DOI: 10.1002/jmv.20372

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  13 in total

1.  Molecular characterization of a new variant of rotavirus P[8]G9 predominant in a sentinel-based survey in central Italy.

Authors:  Filippo Ansaldi; Barbara Pastorino; Laura Valle; Paolo Durando; Laura Sticchi; Pierluigi Tucci; Paolo Biasci; Piero Lai; Roberto Gasparini; Giancarlo Icardi
Journal:  J Clin Microbiol       Date:  2006-12-13       Impact factor: 5.948

2.  Heterogeneity and temporal dynamics of evolution of G1 human rotaviruses in a settled population.

Authors:  Serenella Arista; Giovanni M Giammanco; Simona De Grazia; Stefania Ramirez; Concetta Lo Biundo; Claudia Colomba; Antonio Cascio; Vito Martella
Journal:  J Virol       Date:  2006-08-23       Impact factor: 5.103

3.  Characterization of VP6 genes from rotavirus strains collected in the United States from 1996-2002.

Authors:  Tara K Kerin; Erin M Kane; Roger I Glass; Jon R Gentsch
Journal:  Virus Genes       Date:  2007-06-13       Impact factor: 2.332

4.  Development and validation of DNA microarray for genotyping group A rotavirus VP4 (P[4], P[6], P[8], P[9], and P[14]) and VP7 (G1 to G6, G8 to G10, and G12) genes.

Authors:  Shinjiro Honma; Vladimir Chizhikov; Norma Santos; Masatoshi Tatsumi; Maria do Carmo S T Timenetsky; Alexandre C Linhares; Joana D'Arc P Mascarenhas; Hiroshi Ushijima; George E Armah; Jon R Gentsch; Yasutaka Hoshino
Journal:  J Clin Microbiol       Date:  2007-06-13       Impact factor: 5.948

Review 5.  Burden of rotavirus gastroenteritis in the pediatric population in Central and Eastern Europe: serotype distribution and burden of illness.

Authors:  Isla Ogilvie; Hanane Khoury; Antoine C El Khoury; Mireille M Goetghebeur
Journal:  Hum Vaccin       Date:  2011-05-01

6.  Literature Review on Rotavirus: Disease and Vaccine Characteristics: An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI).

Authors:  E L Ford-Jones; S Calvin
Journal:  Can Commun Dis Rep       Date:  2010-11-30

7.  Unexpected substitution of dominant rotavirus G genotypes in French hospitalized children over five consecutive seasons.

Authors:  A de Rougemont; J Kaplon; P Lebon; F Huet; F Denis; S Alain; L Fourcade; J Grosjean; M-J El-Hajje; D Gendrel; P Pothier
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-10-15       Impact factor: 3.267

8.  Multiplexed one-step RT-PCR VP7 and VP4 genotyping assays for rotaviruses using updated primers.

Authors:  Mathew D Esona; Rashi Gautam; Ka Ian Tam; Alice Williams; Slavica Mijatovic-Rustempasic; Michael D Bowen
Journal:  J Virol Methods       Date:  2015-07-29       Impact factor: 2.014

9.  G-serotypes of group A rotaviruses in Pilsen region (Czechia).

Authors:  P Pazdiora; M Svecová
Journal:  Folia Microbiol (Praha)       Date:  2006       Impact factor: 2.629

10.  Emergence of serotype G12 rotaviruses, Hungary.

Authors:  Krisztián Bányai; Agnes Bogdán; Péter Kisfali; Péter Molnár; Ilona Mihály; Béla Melegh; Vito Martella; Jon R Gentsch; György Szücs
Journal:  Emerg Infect Dis       Date:  2007-06       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.